Loading…
Medical Supplies for Pandemics Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
59pct
3d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Medical Supplies for Pandemics Act of 2021 This bill requires the Department of Health and Human Services (HHS) to undertake various actions to enhance supply chain elasticity for and maintain domestic reserves of critical medical supplies for the Strategic National Stockpile. Specifically, HHS must increase emergency stocks of supplies, geographically diversify production of supplies, and enter cooperative agreements or partnerships for purposes of supporting domestic production of supplies and replenishing supplies in the stockpile. The department's authority to enter such agreements and partnerships terminates on September 30, 2024.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, (S. 3799); issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260); issues related to the expedition of critical medical supplies at US ports.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306);Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S.1974). S. 3799, PREVENT Pandemics Act; USICA - COMPETES Act Conference Agreement; Medicare CY23 IPPS proposed rule provision on domestic N95 respirators.
Client expense: Not reported · Firm income: $110,000
2022 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement & regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932, S.4449/H.R.8188, CY23 CLFS); Precision Medicine (H.R. 6000/H.R. 5989); COVID preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463, P.L. 117-328); Future pandemic preparedness & response (S. 3799, H.R. 7152/S. 3534, H.R. 3635/S. 1974, P.L. 117-328); User Fees Reauthorization (S. 4328/H.R. 7667); ARPA-H (S. 3819/H.R. 5585); Biotechnology and biomanufacturing.
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · fourth_quarter · Disaster Planning/Emergencies
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $870,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
| Democratic |
| CA |
| Thomas R. Suozzi | Democratic | NY |
| William R. Timmons IV | Republican | SC |
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306);Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S.1974). S. 3799, PREVENT Pandemics Act; USICA - COMPETES Act Conference Agreement; Medicare CY23 IPPS proposed rule provision on domestic N95 respirators.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness. H.R.3635/S.1974 - Strengthening America's Strategic National Stockpile Act of 2021. H.R.3463/S.1693 - Medical Supplies for Pandemics Act of 2021. Issues related to supply chain for personal protective equipment (PPE). Issues related to personal protective equipment (PPE) and pandemic preparedness. S.3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022"; H.R. 4128/S. 2209; S. 4348 Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; The Verifying Accurate Leading-edge IVCT Development Act of 2021; Issues related to public health emergency preparedness.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, (S. 3799); issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260); issues related to the expedition of critical medical supplies at US ports.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Disaster Planning/Emergencies
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness. H.R.3635/S.1974 - Strengthening America's Strategic National Stockpile Act of 2021. H.R.3463/S.1693 - Medical Supplies for Pandemics Act of 2021. Issues related to supply chain for personal protective equipment (PPE). Issues related to personal protective equipment (PPE) and pandemic preparedness. S.3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, S. 3799; issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260); issues related to the expedition of critical medical supplies at US ports.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306);Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S.1974). S. 3799, PREVENT Pandemics Act; USICA - COMPETES Act Conference Agreement; Medicare CY23 IPPS proposed rule provision on domestic N95 respirators.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · second_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $580,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · second_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R. 7667, the "Food and Drug Amendments of 2022".
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Client expense: $200,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues related to H.R. 8592, the EMS Counts Act of 2020. Issues related to the implementation of H.R. 1319, the American Rescue Plan Act of 2021. Issues related to H.R. 1609 / S.149, the Treatment in Place Act. Issues related to H.R. 3463 / S. 1693, the Medical Supplies for Pandemics Act of 2021. Issues related to H.R. 3635 / S. 1974, the Strengthening America's Strategic National Stockpile Act of 2021. Issues related to S. 3910, the EMS Staffing and Support Act. Issues related to S. 2037, the Protecting Access to Ground Ambulance Medical Services Act of 2021. Issues related to H.R. 7850 / S. 4269, the Prevent BLEEDing Act of 2022. Issues related to EMS funding.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Healthcare supply chain, resiliency and product continuity; The Medical Supplies for Pandemics Act (H.R. 3463/S.1693) concerning medical product supply chain preparedness; The Strengthening Americas Strategic National Stockpile Act (H.R. 3635/S.1974) concerning medical product supply chain preparedness; Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (S.3799) concerning medical product supply chain preparedness.
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Disaster Planning/Emergencies
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act (S. 1693 and H.R. 3463), PREVENT Pandemics Act, S. 3799; issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021 (S. 1260).
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 2297, MIND Act. S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021. H.R. 955, Medicaid Reentry Act of 2021. H.R. 379, Improving Social Determinants of Health Act of 2021. H.R. 2903, CONNECT for Health Act of 2021. S. 1512 CONNECT for Health Act of 2021. S. 151, COVID HCBS Relief Act of 2021. H.R. 525, COVID HCBS Relief Act of 2021. H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1388, Prescription Pricing for the People Act of 2021. S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1693, Medical Supplies for Pandemics Act of 2021. H.R. 3463, Medical Supplies for Pandemics Act of 2021. H.R. 5376, Build Back Better Act. H.R. 2471, Consolidated Appropriations Act, 2022 (P.L. 117-103). H.R. 4521, America COMPETES Act of 2022. S. 3799, PREVENT Pandemics Act. H.R. 6963, Accelerated Approval Integrity Act of 2022. H.R. 6996, Accelerating Access for Patients Act of 2022. H.R, 7007, COVID Supplemental Appropriations Act, 2022. H.R. 6833, Affordable Insulin Now Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness. H.R.3635/S.1974 - Strengthening America's Strategic National Stockpile Act of 2021. H.R.3463/S.1693 - Medical Supplies for Pandemics Act of 2021. Issues related to supply chain for personal protective equipment (PPE). Issues related to personal protective equipment (PPE) and pandemic preparedness. S.3799 - PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974). S. 3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747/S.1018-Access to TESTs Act; H.R. 3463/S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Disaster Planning/Emergencies
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534); Cancer Moonshot 2.0; Health Equity.
Client expense: $740,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · first_quarter · Health Issues
Issues related to H.R. 8592, the EMS Counts Act of 2020. Issues related to the implementation of H.R. 1319, the American Rescue Plan Act of 2021. Issues related to H.R. 1609 / S.149, the Treatment in Place Act. Issues related to H.R. 3463 / S. 1693, the Medical Supplies for Pandemics Act of 2021. Issues related to H.R. 3635 / S. 1974, the Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Client expense: $200,000 · Firm income: Not reported
Government targets: Architect of the Capitol (AOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act: H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Medical supply chain, particularly in response to the COVID-19 pandemic; Endless Frontier Act; HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs; S. 1693/H.R. 3463, Medical Supplies for Pandemics Act of 2021; S. 1974/H.R. 3635, Strengthening Americas Strategic National Stockpile Act of 2021; Healthcare product exclusions from Section 301 tariffs
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2021 · fourth_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2021 · fourth_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative outreach related to executive action surrounding the HHS Rebate rule. Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3). Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (P.L. 117-2). Legislative outreach and monitoring the implementation of H.R. 3684, Infrastructure Investment and Jobs Act. (P.L. 117-58). Legislative and administrative monitoring and outreach on activity related to reconciliation and the congressional budget resolution. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 2297, MIND Act. S. 439, Coronavirus Medicaid Response Act. H.R. 1353, Coronavirus Medicaid Response Act. S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021. H.R. 955, Medicaid Reentry Act of 2021. H.R. 379, Improving Social Determinants of Health Act of 2021. H.R. 2903, CONNECT for Health Act of 2021. S. 1512 CONNECT for Health Act of 2021. S. 151, COVID HCBS Relief Act of 2021. H.R. 525, COVID HCBS Relief Act of 2021. H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1388, Prescription Pricing for the People Act of 2021. H.R. 928, American Family Act of 2021. S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1693, Medical Supplies for Pandemics Act of 2021. H.R. 3463, Medical Supplies for Pandemics Act of 2021. H.R. 5376, Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness; Strengthening the Strategic National Stockpile Act (H.R. 3635/S. 1974); Medical Supplies for Pandemics Act (H.R. 3463/S. 1693); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436/S. 308); Issues related to supply chain for personal protective equipment (PPE); Issues related to personal protective equipment (PPE) and pandemic preparedness.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2021 · fourth_quarter · Health Issues
Issues related to the distribution of health care products; issues related to pandemic preparedness, including Medical Supplies for Pandemics Act, S. 1693 and H.R. 3463; issues related to supply chain security and transportation of medical supplies, including United States Innovation and Competition Act of 2021, S. 1260.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Issues relating to COVID diagnostic testing; H.R. 747 and S.1018-Access to TESTs Act; H.R. 3463 and S. 1693-Medical Supplies for Pandemics Act of 2021; S.1974-Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Consumer Issues/Safety/Products
S. 308/H.R. 1436, PPE In America Act S. 936/H.R. 5502, INFORM Consumers Act S. 1260/H.R. 2731, Endless Frontier Act / U.S. Innovation & Competition Act S. 1693/H.R. 3463, Medical Supplies for Pandemics Act Revolving Stockpile for PPE PPE Issues, generally, no specific legislation Efforts to combat counterfeits and price gouging during COVID Implementation of the CARES Act, Public Law 116-136
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Energy, Dept of, Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · fourth_quarter · Disaster Planning/Emergencies
S. 308./H.R. 1436, PPE In America Act S. 936/H.R. 5502, INFORM Consumers Act H.R. 3429/H.R. 5374/S.1843, SHOP SAFE Act S. 1260/H.R. 2731, Endless Frontier Act / U.S. Innovation & Competition Act S.1693/H.R. 3463, Medical Supplies for Pandemics Act Revolving Stockpile for PPE / Strategic National Stockpile (SNS) reforms Efforts to combat counterfeits and price gouging during COVID Data collection - PPE supplies and vaccine distribution DOD support for COVID response Efforts to encourage domestic manufacturing of PPE and pandemic response Implementation of the CARES Act, Public Law 116-136
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Energy, Dept of, Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · fourth_quarter · Health Issues
Issues related to H.R. 2550, Prevent BLEEDing Act of 2019 and the Stop the Bleed Campaign. Issues related to H.R. 8592, the EMS Counts Act of 2020. Issues related to H.R. 1319, the American Rescue Plan Act of 2021. Issues related to H.R. 1609 and S.149, To amend title XI of the Social Security Act to provide Secretarial authority to temporarily waive or modify application of certain Medicare requirements with respect to ambulance services furnished during certain emergency periods. Issues related to H.R. 3463 / S. 1693, the Medical Supplies for Pandemics Act of 2021. Issues related to H.R. 3635 / S. 1974, the Strengthening America's Strategic National Stockpile Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
2021 · fourth_quarter · Health Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306)
Client expense: $240,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · fourth_quarter · Disaster Planning/Emergencies
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to H.R. 3684, the Infrastructure Investment and Jobs Act, and other domestic manufacturing and emergency preparedness matters concerning SNS and ASPR. As well as H.R. 5376, the Build Back Better Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
Medical supply chain, particularly in response to the COVID-19 pandemic; Endless Frontier Act; HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs; Medical Supplies for Pandemics Act of 2021 (S. 1693/H.R. 3463); Strengthening Americas Strategic National Stockpile Act of 2021 (S. 1974/H.R. 3635)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT). Legislative outreach related to executive action surrounding the HHS Rebate rule. S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3). Legislative outreach and monitoring the implementation of H.R. 1319, American Rescue Plan Act of 2021 (117-2). Legislative and administrative monitoring and outreach on activity related to reconciliation and the congressional budget resolution. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 2297, MIND Act. S. 439, Coronavirus Medicaid Response Act. H.R. 1353, Coronavirus Medicaid Response Act. S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021. H.R. 955, Medicaid Reentry Act of 2021. H.R. 379, Improving Social Determinants of Health Act of 2021. H.R. 2903, CONNECT for Health Act of 2021. S. 1512 CONNECT for Health Act of 2021. H.R. 3684, Infrastructure Investment and Jobs Act. H.R. 4161 To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes. S. 151, COVID HCBS Relief Act of 2021. H.R. 525, COVID HCBS Relief Act of 2021. H.R. 3203, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1388, Prescription Pricing for the People Act of 2021. H.R. 928, American Family Act of 2021. S. 773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S. 1693, Medical Supplies for Pandemics Act of 2021. H.R. 3463, Medical Supplies for Pandemics Act of 2021. H.R. 5376, Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Issues related to the Strategic National Stockpile and pandemic preparedness; Strengthening the Strategic National Stockpile Act (H.R. 3635/S. 1974); Medical Supplies for Pandemics Act (H.R. 3463/S. 1693); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436/S. 308); Implementation of American Rescue Plan provisions related to personal protective equipment (PPE); Issues related to supply chain for personal protective equipment (PPE); Issues related to pandemic preparedness.
Client expense: Not reported · Firm income: $60,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2021 · third_quarter · Health Issues
PPE supply chain and COVID-19; Strategic National Stockpile; PPE Manufacturing; Support for domestic sourcing of medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Consumer Issues/Safety/Products
S. 308/H.R. 1436, PPE In America Act S. 936, INFORM Consumers Act S. 1260, Endless Frontier Act / U.S. Innovation & Competition Act S. 1693/H.R. 3463, Medical Supplies for Pandemics Act Revolving Stockpile for PPE PPE Issues, generally, no specific legislation Efforts to combat counterfeits and price gouging during COVID Implementation of the CARES Act, Public Law 116-136
Client expense: $700,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Energy, Dept of, Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · third_quarter · Disaster Planning/Emergencies
S. 308./H.R. 1436, PPE In America Act S. 936, INFORM Consumers Act H.R. 3429/H.R. 5374/S.1843, SHOP SAFE Act S. 1260, Endless Frontier Act / U.S. Innovation & Competition Act S.1693/H.R. 3463, Medical Supplies for Pandemics Act Revolving Stockpile for PPE / Strategic National Stockpile (SNS) reforms Efforts to combat counterfeits and price gouging during COVID Data collection - PPE supplies and vaccine distribution DOD support for COVID response Efforts to encourage domestic manufacturing of PPE and pandemic response Antimicrobial wipes for COVID response Implementation of the CARES Act, Public Law 116-136
Client expense: $700,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Commerce, Dept of (DOC), Energy, Dept of, Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Patent & Trademark Office (PTO), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act. H.R. 747/S.1018 The Access to Technology and Equipment for Same-day Tests Act. H.R.1436/S. 308 Protecting Providers Everywhere in America Act. H.R. 3635/S. 1974 Strengthening America's Strategic National Stockpile Act H.R. 3463/S.1693 Medical Supplies for Pandemics Act. Build Back Better Reconciliation Package Issues related to public health emergency preparedness
Client expense: $175,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office